GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice

OBJECTIVE: Analogues of GDF15 (Growth Differentiation Factor 15) are promising new anti-obesity therapies as pharmacological treatment with GDF15 results in dramatic reductions of food intake and body weight. GDF15 exerts its central anorexic effects by binding to the GFRAL receptor exclusively expr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Metab
Autors principals: Frikke-Schmidt, Henriette, Hultman, Karin, Galaske, Joseph W., Jørgensen, Sebastian B., Myers, Martin G., Seeley, Randy J.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6407365/
https://ncbi.nlm.nih.gov/pubmed/30685336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2019.01.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars